Publizoom

Award notice Supplies

26Far019 c)suministro de medicamentos "exclusivos" (i)

Notice published in Spanish. The AI analysis summarises it for you in your language.

Public buyer
CONSORCIO CORPORACIÓ SANITÀRIA PARC TAULÍ DE SABADELL
Sabadell
Place of performance
Sabadell
Estimated value
€10,074,251 excl. VAT
Amount awarded
€808,514 excl. VAT
Planned end of contract
14 April 2028
likely re-tender around October 2027
Bids received
1
Procedure
Open procedure
Any company may submit a bid.
Publication
19 October 2026
Notice language
Spanish

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Create my free account

Unlimited analyses during the 14-day Pro trial, no card needed.

Description

SUMINISTRO DE MEDICAMENTOS "EXCLUSIVOS" (I)

Awarded to

8 lots

  • ECX213-231-232 SUMINISTRO DE MEDICAMENTOS "EXCLUSIVOS" (I)
  • ECX210 SUMINISTRO DE MEDICAMENTOS "EXCLUSIVOS" (I)
  • ECX246 SUMINISTRO DE MEDICAMENTOS "EXCLUSIVOS" (I)
  • ECX249 SUMINISTRO DE MEDICAMENTOS "EXCLUSIVOS" (I)
  • ECX202-2020 SUMINISTRO DE MEDICAMENTOS "EXCLUSIVOS" (I)
  • ECX203-214-218-233 SUMINISTRO DE MEDICAMENTOS "EXCLUSIVOS" (I)
  • ECX215 SUMINISTRO DE MEDICAMENTOS "EXCLUSIVOS" (I)
  • DESIERTOS-EXC206-207-211-222-226-228-235-237-238-241-242-243-244-245-247-248-250-254

CPV codes

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33600000

Winning prices for comparable contracts

A quarter below
€350,000
Median
€861,120
A quarter above
€2,267,877

Amounts awarded (excl. VAT) over the last 3 years for 257 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.

Similar contracts already awarded

ContractWinnerAmount
26Far019 a)suministro de medicamentos "exclusivos" (i)
CONSORCIO CORPORACIÓ SANITÀRIA PARC TAULÍ DE SABADELL · 19 October 2026
ABBVIE SPAIN S.L. UNIPERSONAL
ALFASIGMA ESPAÑA S.L
ALMIRALL S.A.
ALNYLAM PHARMACEUTICALS SPAIN SL
AOP ORPHAN PHARMACEUTICALS IBERIA, S.L
ARGENX SPAIN SL
BAXTER, S.L.
AstraZeneca Fca. Spain, S.A.
€1,108,582
26Far019 b)suministro de medicamentos "exclusivos" (i)
CONSORCIO CORPORACIÓ SANITÀRIA PARC TAULÍ DE SABADELL · 19 October 2026
BAYER HISPANIA S.L.U.
BOEHRINGER INGELHEIM ESPAÑA, S.A.
CASEN RECORDATI, S.L.
Esteve Pharmaceuticals, S.A.
EUROMED PHARMA SPAIN SL
GLAXOSMITHKLINE, S.A.
INCYTE BIOSCIENCES IBERIA, S.L.
JANSSEN CILAG S.A.
€540,765
Expediente 2204/2025, nº siglo 578/2025, cca +6.i+e9q8j contr bam 2026 203199, con la empresa pfizer, s.l
Servicio Andaluz de Salud. Hospital Universitario Puerta del Mar · 22 October 2026
PFIZER, S.L €164,527,501
MEDICAMENTO CARVYKTI 3,2x10e6-1x10e8 células dispersión, CON DESTINO AL HOSPITAL UNIVERSITARIO DE LA PRINCESA
Hospital Universitario de la Princesa · 22 October 2026
JANSSENG-CILAG, S.A. €2,936,960
“Suministro IOMEPROL (IOMERON) Y HEPARINA SODICA 20 UI/ML (FIBRILIN) de distribución exclusiva con destino al servicio de Farmacia Hospital Clínico San Carlos de Madrid"
HOSPITAL CLINICO SAN CARLOS · 22 October 2026
LABORATORIOS FARMACEUTICOS ROVI, S.A. €224,016

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 719177-2026.